Welcome to our dedicated page for Guardian Pharmacy Services SEC filings (Ticker: GRDN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Guardian Pharmacy Services, Inc. filings document the reporting obligations of a NYSE-listed long-term care pharmacy services company with Class A common stock. Recent Form 8-K filings furnish operating results, financial guidance, investor presentation materials, and exhibits tied to the company’s pharmacy services business.
Proxy and current-report filings also cover board elections, advisory compensation votes, stockholder voting results, material stock purchase agreements, lock-up arrangements, and conversion-related disclosures involving Class A and Class B common stock. These records describe governance, ownership, capital-structure mechanics, registered securities, and matters linked to the company’s September 2024 corporate reorganization.
Guardian Pharmacy Services, Inc. major shareholders filed an amended Schedule 13D to update their ownership and recent stock sale. On March 20, 2026, the reporting group sold an aggregate 5,880,000 shares of Class A common stock under an underwriting agreement, including the underwriters’ full exercise of an additional 900,000-share option.
After these sales, the reporting persons collectively beneficially own 17,929,985 shares of Class A common stock, representing about 36.0% of the class. That percentage is based on 49,781,181 shares, which combines 36,259,762 shares outstanding as of March 13, 2026 and 13,521,419 shares to be issued upon automatic Class B-to-Class A conversion on March 28, 2026.
The filing also describes 180-day lock-up agreements entered into with the underwriters on March 18, 2026, restricting additional sales or hedging transactions in the company’s common stock without prior written consent from BofA Securities, Inc. and Jefferies LLC.
Pharmacy Investors, LLC, a member of a 10% owner group of Guardian Pharmacy Services, Inc., sold 827,636 shares of Class A common stock in an open-market transaction on March 20, 2026 at an average price of $29.6825 per share. After this sale, Pharmacy Investors, LLC still directly holds 1,035,928 shares of Guardian’s Class A common stock. The shares were sold as part of an underwriting agreement involving the company and other selling stockholders.
Guardian Pharmacy Services director and officer Morris David K reported an open-market sale of 187,855 shares of Class A common stock on March 20, 2026 at an average price of $29.6825 per share. After the sale, he directly holds 254,472 shares. The shares were sold pursuant to an underwriting agreement with BofA Securities and Jefferies as representatives of the underwriters.
Guardian Pharmacy Services director and officer Fred Burke reported an open-market sale of 671,432 shares of Class A common stock at an average price of $29.6825 per share. The shares were sold pursuant to an underwriting agreement involving the company and other selling stockholders. After this transaction, Burke directly owns 840,413 shares of Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc. officer Forbes Kendall reported an open-market sale of 346,672 shares of Class A common stock at an average price of $29.6825 per share. The shares were sold pursuant to an underwriting agreement with BofA Securities and Jefferies. After the transaction, Kendall directly holds 453,256 shares.
Cardinal Equity Fund, L.P., a member of the 10% owner group of Guardian Pharmacy Services, Inc., reported an open-market sale of 275,728 shares of Class A common stock on March 20, 2026 at an average price of $29.6825 per share.
The shares were sold pursuant to an underwriting agreement among the company, certain selling stockholders, and underwriters led by BofA Securities and Jefferies. Following this transaction, Cardinal Equity Fund directly holds 345,123 shares of Guardian Pharmacy Class A common stock.
Guardian Pharmacy Services director and 10% owner Thomas J. Salentine Jr. reported a large stock sale executed by an affiliated entity. Bindley Capital Partners I, LLC, an entity associated with him, sold 3,570,677 shares of Class A Common Stock on March 20, 2026 at an average price of $29.6825 per share in an underwritten offering led by BofA Securities and Jefferies. Following the transaction, the filing shows 4,469,316 shares held indirectly through Bindley Capital Partners I, LLC and 35,714 shares held directly in his name.
Bindley Capital Partners I, LLC, a 10% owner of Guardian Pharmacy Services, Inc., reported selling 3,570,677 shares of Class A common stock at an average price of $29.6825 per share on March 20, 2026. The sale was made as part of an underwritten offering pursuant to an underwriting agreement with BofA Securities and Jefferies. After this transaction, Bindley Capital Partners I, LLC continues to hold 4,469,316 shares of Guardian Pharmacy Services Class A common stock.
Guardian Pharmacy Services director-related entities sold shares in an underwritten offering. On March 20, 2026, Pharmacy Investors, LLC sold 827,636 shares of Class A common stock at $29.6825 per share, while Cardinal Equity Fund, L.P. sold 275,728 shares at the same price.
Both transactions are indirect holdings associated with director John Ackerman and were executed as open-market sales pursuant to an underwriting agreement with BofA Securities and Jefferies as representatives of the underwriters. After these sales, Pharmacy Investors, LLC still held 1,035,928 shares and Cardinal Equity Fund, L.P. held 345,123 shares.
Guardian Pharmacy Services, Inc. director and 10% owner William E. Bindley reported an indirect open‑market sale of 3,570,677 shares of Class A common stock at an average price of $29.6825 per share. The shares were held by Bindley Capital Partners I, LLC and were sold pursuant to an underwriting agreement with BofA Securities, Inc. and Jefferies LLC. Following this secondary sale, Bindley Capital Partners I, LLC continues to hold 4,469,316 shares of Class A common stock indirectly associated with Bindley.